Hepatitis aguda por ticlopidina. Presentación de 12 casos y revisión de la literatura
Ángeles E. Pizarro(Hospital Regional Universitario de Málaga), Raúl J. Andrade, A Ruiz-Montero, M J Soto-Conesa, Ruth de Francisco, M. Isabel Lucena(Hospital Clínico Universitario Virgen de la Victoria), José Antonio Durán(Institut Químic de Sarrià), Herminia Sanchez-Martinez, Miren García‐Cortés(Hospital Clínico Universitario Virgen de la Victoria), J M Pérez-Moreno
Cited by 13
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
|Gastroenterology|2005|1k
Inflammatory Molecules in the Tears of Patients with Keratoconus
|Ophthalmology|2005|384